Company page

Aelis Farma Sa

Aelis Farma SA is a public company listed on the French market under the ticker AELIS, with a market capitalization of approximately €16.7 million. The company focuses on developing innovative therapies for central nervous system disorders. Aelis Farma is committed to advancing its research and development efforts to address unmet medical needs in this field.